Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Emphysematous cystitis: a review of 135 cases
- Anil Thomas, B. Lane, Arun Z. Thomas, E. Remer, S. Campbell, D. Shoskes
- BJU international
- 1 July 2007
To review recently published data on emphysematous cystitis (EC), a potentially life‐threatening condition characterized by air within the bladder wall, and that most typically affects middle‐aged… Expand
Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection.
DGF is an important independent predictor of poor graft survival, and newer immunosuppressive strategies must minimize nonimmune and immune renal injury if long-term graft survival is to improve. Expand
Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis.
- M. Cruz-Correa, D. Shoskes, +4 authors F. Giardiello
- Clinical gastroenterology and hepatology : the…
- 1 August 2006
The combination of curcumin and quercetin appears to reduce the number and size of ileal and rectal adenomas in patients with FAP without appreciable toxicity. Expand
Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity.
Applying the UPOINT system to patients with CPPS can discriminate clinical phenotypes, allowing for hypothesis testing for etiology and therapy and it is proposed that multimodal therapy might best be guided by the UpOINT phenotype. Expand
Prevalence of Corynebacterial 16S rRNA Sequences in Patients with Bacterial and “Nonbacterial” Prostatitis
- Michael A. Tanner, D. Shoskes, A. Shahed, N. Pace
- Biology, Medicine
- Journal of Clinical Microbiology
- 1 June 1999
It is shown that microorganisms associated with prostatitis generally occur as complex microbial communities that differ between patients, and that microbial communities distinct from those associated with prostate fluid may occur at low levels in normal prostatic fluid. Expand
Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial.
Therapy with the bioflavonoid quercetin is well tolerated and provides significant symptomatic improvement in most men with chronic pelvic pain syndrome. Expand
Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes
A six-domain phenotype is proposed, which can classify patients clinically and can direct the selection of therapy in the most evidence based multimodal manner, and is flexible and responsive to new biomarkers and therapies as their utility and efficacy are proven. Expand
Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors.
It is shown that age and gender are important factors determining normal GFR in living kidney donors, and a significant doubling in the rate of GFR decline in donors over age 45 as compared to younger donors. Expand
A randomized placebo‐controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis)
To determine if finasteride can reduce symptoms in men with a clinical diagnosis of chronic nonbacterial prostatitis (National Institutes of Health, NIH, category IIIA chronic pelvic pain syndrome,… Expand
Cytokine polymorphisms in men with chronic prostatitis/chronic pelvic pain syndrome: association with diagnosis and treatment response.
Patients with the chronic pelvic pain syndrome are more likely to have a low IL-10 producing genotype, suggesting autoimmunity as a potential etiology. Expand